| Tag | Content |
|---|
EnhancerAtlas ID | HS098-24203 |
Organism | Homo sapiens |
Tissue/cell | HSMM |
Coordinate | chr17:44221240-44223220 |
SNPs | | Number: 1 | ID | Chromosome | Position | Genome Version |
|
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| RORA(var.2) | MA0072.1 | chr17:44221474-44221488 | TATAATTAGGTCAA | + | 7.47 | | RUNX1 | MA0002.2 | chr17:44221773-44221784 | AAACCACAGAA | - | 6.32 |
|
| | Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
| SE_09447 | chr17:44220972-44224115 | CD14 | | SE_11745 | chr17:44220909-44226381 | CD20 | | SE_13432 | chr17:44221381-44222521 | CD34_Primary_RO01536 | | SE_18395 | chr17:44221223-44224075 | CD4p_CD25-_Il17-_PMAstim_Th |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 4 | Chromosome | Start | End |
| chr17 | 44222069 | 44222124 | | chr17 | 44221587 | 44221653 | | chr17 | 44221663 | 44222002 | | chr17 | 44222148 | 44222736 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH17I046145 | chr17 | 44222461 | 44223966 |
|
Enhancer Sequence | AGATTGGTTG AGTGATATCC GAGGACCACA GAGCTAGTAA AATTATGGAG CTAGAACTTG 60
AAGTCTGATT CCAAATCACA TGTTTCCTAT GCTACCCCAA ACAAAGGGAG TATTTTCTAC 120
AGTGGCATTA CAACAGACCA AGTAACAGCA GAGGTAAAAC AAGTTTCACA TGTCTGTGGC 180
TCTTTGTTTT TTACAAGTTT TTATTACTTT GTCATGGGGG GGAAAACGAA AAATTATAAT 240
TAGGTCAAGG AAAGATATAA CTATACTACT ACTATCATTC TGAAGGAAGG GAAGGTATAC 300
CTTCTAAGTC CTGCATAGTT TAAAAATTCC CATTACTTGC GAGACCAGGT GAGACTGCAC 360
AGTTCTAGAC TTCCTATCGT GTGCCAAAAC TCTAGGGATA ATCAAAAAAT GTTTGTTGAA 420
TGAACGCTAA TTTAAAATAG AAAAAGAAAT TCCAGATTTC CTCCTCAGTA CAAGAGGCCT 480
GCAACAACAA ACTTCTGAAA TACCAGCAGT CTACTAATTG CATATTCAAA TTTAAACCAC 540
AGAAAGTTGA ATCAACTCTG CCAATTTCTG GGACTCTCTA AATGAACTCT TAATACAAAA 600
ATACATACTC AGGCTCAGCA TTTTTTCTAA TCATTTACAA AAGTAAAAGG ACGTCAGGAC 660
AAGTTCTGGT GAAATTTTAT AAACAGCCAT GAATTGCAGC TGTAGACTGC CAGATACATA 720
ACCTGTATAT GACAGGGGGT ACCACGTGGA AATTAGAGAC ATCCCCCTTC ACCAAAAAGA 780
TTATATCCAG GGGATACTAC ATAATAAAAA AAAAATCTGA AAAATGTAAT GGGATTAAGA 840
TCCTTTAGAA TAGGCTAGTA GTGATGATTT TGCTTTTTCA GTCCCCTCCT CACAAACAAA 900
TGATGATGAC ACTGCCCTTA GCTTTCTATG TGCAAAGACA GTATTAACCT TCCCAGGCCA 960
AACTTACGAC TACACCTTTT CCACACGAAA TGCAAGGCAT TTCTAACTCC CCAGATTACC 1020
TCACATTCGT TGGATGCCAC ACAATAGATT ATAAAGTATC AAGATATATA TTAATTTTTA 1080
AAAGTTCACC AGGAGTTGGA TATTCTAAAC TGGGTTTCTG ATTCTTAACA GTGAGAATGA 1140
AGTCAAGCTC CTTATTTGGT GGTTAGAGGA GAGGATTTGG CCAGAAATAA TTCTTTTAGG 1200
ATTGACAGAC AAGTACTACT TAAGTTCTAT CATCTCATCC AAAAACTTGC TTCTTATATT 1260
CTGCTTTTAA CCCGATCTAC ACAATGAAAA GCCACGGAGA CTAGTTTTGC ATGAAAGCAA 1320
AGGACTTTTC TAATATGACT TCAGAGCATG CCATGCTTTA AAGTCCATGT TCAACCACTT 1380
ACTATCATTT TCCAACTCAC TCTCTATGGG CCCATCCCAT ATTTCAACTA CAGGTATACC 1440
TCCTGGCCCT TTCTATTTCA TAAGCTTCTT TGGAAGACAA ATCTACTGAT TTATGCAATA 1500
AACTTTCTAC CTCTACTTAA CCAATTTGAT AATTTAATAG CTGGAGATAA TTCTAAATTC 1560
CCCAAACCTT AATCAAGAAT TTTGGAAAAA AAGAGCTATC TAGAACAGTT ATCTTCCTGA 1620
AAACACTGTT GTGCTAAACT GAAACACAGC CTTTTCTCAA GAGCTAAGCA GCTACTTGGG 1680
TCTACATTTT AATGCACTAA ATAATTTTAT AAGATCATGT TTGAAACCAA AAAACCCAAA 1740
AAGGATTGTC AAGCTAGGTC AGCTTACAAA ACCCCTTCTG TTATGAACTA GGAAATCAAA 1800
CAACAAAACA TAAGCTCTAG GAAATGAGCA TGGAGGTGCT CCATCCATAC TAGCTTTTCC 1860
TTGTTTTTTT CTTGAGAGGA GTGACTCTCT GTCACCCAGG CTGGAGTGTA GTGATGCAAT 1920
CCTGGTTCAC TCCAACCTCC ACCTCCTGAG TTCAAGGGAT TCTCCTGCCT CAGCCTCCCG 1980
|
